NDC 51662-1297
Dexamethasone Sodium Phosphate 4 mg per 1 mL injection
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hikma Pharmaceuticals USA Inc.'s NDC 0641-6146.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Hikma Pharmaceuticals USA Inc. names for other drugs.
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Nov 6, 2017 · Class III · West-Ward Pharmaceuticals Corp.
Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).
Lots: Lot #: 106390, 106393, 106395, Exp 10/18 - Nov 6, 2017 · Class III · West-Ward Pharmaceuticals Corp.
Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).
Lots: Lot #: 106352, Exp 10/18
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Dexamethasone: every company that makes it
- Form
- injection, intra-articular; intralesional; intramuscular; intravenous; soft tissue
- Strength
- 4 mg per 1 mL
- Approval
- ANDA ANDA084282
- On the market since
- Jul 21, 2019
- Package NDCs
51662-1297-151662-1297-251662-1297-3- Official label
- DailyMed (National Library of Medicine), updated Jan 30, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?